Comparison of methotrexate (NSC-740) and testosterone propionate (NSC-9166) in the treatment of breast cancer.
D001859:Bone Neoplasms / Q000188:drug therapy; D001932:Brain Neoplasms / Q000188:drug therapy; D001943:Breast Neoplasms / Q000188:drug therapy*; D005260:Female; D005770:Gastrointestinal Neoplasms / Q000188:drug therapy; D006801:Humans; D008113:Liver Neoplasms / Q000188:drug therapy; D008175:Lung Neoplasms / Q000188:drug therapy; D008593:Menopause; D008727:Methotrexate / Q000009:adverse effects / Q000627:therapeutic use* / Q000633:toxicity; D009362:Neoplasm Metastasis; D009364:Neoplasm Recurrence, Local; D012878:Skin Neoplasms / Q000188:drug therapy; D013739:Testosterone / Q000009:adverse effects / Q000627:therapeutic use* / Q000633:toxicity
D013739:Testosterone; D008727:Methotrexate